CDKN2B-AS1 and atherosclerosis: ANRIL, like other ncRNAs, are able to regulate the expression of their neighboring genes via cis-trans gene regulation, and further influence microRNA signaling, thus providing multiple potential therapeutic targets for the treatment of atherosclerosis.